Halloween Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Chris Blumas
Alcon IncALCTOP PICKOct 14, 2026
Chris BlumasOwned
N/A
Stock price when the opinion was issued
$63.15
As of Oct 13, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Proad product array. Not widely followed. Very strong grower.
Thomas GalvinOwned
biotechnologypharmaceutical
European-based, but US operating platform. Contact lenses + surgical supplies (corrective procedures), each with 50% of revenues. Demographics is supportive even of eye health, and increased screen time also feeds into that. Reasonable valuation at 17x PE, 4-5% FCF yield.
(Analysts’ price target is $86.88)Attractive, defensive business in this environment. Yield is 0.57%.